Collagenase in the Treatment of Cellulite

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00261144

Enrollment

Registered

2005-12-02

Start date

2013-02-28

Completion date

2014-03-31

Last updated

2012-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cellulite

Brief summary

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

Detailed description

This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.

Interventions

DRUGCollagenase

One 0.58mg injection every two weeks for six weeks (total three 0.58mg injections)

BIOLOGICALBiological

Collagenase injection

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* 10 x 10 cm area of cellulite of the posterolateral thigh(s)

Exclusion criteria

* any chronic, serious or uncontrolled medical condition * inability to conform to study visits (12-15 per year)

Design outcomes

Primary

Measure	Time frame
Reduction and/or elimination of cellulite in the posterolateral thigh	6 months

Countries

United States

Contacts

Primary ContactMarie A Badalamente, PhD

Marie.Badalamente@stonybrookmedicine.edu631 444 2215

Backup ContactGail Trocchio

Gail.Trocchio@stonybrookmedicine.edu631 444 2215

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026